Add like
Add dislike
Add to saved papers

Congruent elbow plate fixation of olecranon fractures.

OBJECTIVES: We hypothesize that clinical results and patient outcomes following treatment of olecranon fractures with a congruent elbow plating system will be comparable to other available plating systems. Our results will be compared to previously published reports.

DESIGN: Retrospective study.

SETTING: Level 1 academic referral center.

PATIENTS/PARTICIPANTS: The trauma registry was reviewed to identify all olecranon fractures treated with open reduction and internal fixation between January 2001 and December 2004 using the Mayo Congruent Elbow Plate system. Thirty-two patients were identified. Postoperative range of motion was initiated within 2 weeks postoperatively. Mean time to follow-up was 2.2 years (0.7-5.1). All patients had follow-up radiographs. Outcome scores were available on 24 of the 32 patients.

INTERVENTION: Medical records and radiographs of all patients were reviewed.

MAIN OUTCOME MEASUREMENTS: Objective measures included radiographic healing, postoperative range of motion, and complications. Subjective functional results included Mayo Elbow Performance (MEP) score; Disability of the Arm, Shoulder, and Hand (DASH) score; and patient satisfaction.

RESULTS: Of the 32 fractures, 30 went on to union. Three patients had symptomatic hardware that was removed. There was 1 infection and 1 failure of fixation also requiring hardware removal. Average arc of motion was 120 degrees. Subjective follow-up was available in 75% of patients. Mean DASH was 32. Mean MEPS was 89, with 92% good or excellent results.

CONCLUSIONS: Congruent anatomic plating is a safe, effective option for the treatment of olecranon fractures with a low rate of hardware removal and stability with early motion.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app